Hong Kong patients could have quicker access to new drugs if authorities streamline certification process, experts say
Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.
Approval process is slowed down by current requirements, say experts calling for a change of rules.